TY - JOUR
T1 - Crystallization and microstructure analysis of calcium phosphate-based glass ceramics for biomedical applications
AU - Zhang, Yong
AU - Santos, J. D.
N1 - Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].
PY - 2000/7
Y1 - 2000/7
N2 - Calcium phosphate glasses and glass ceramics (CaO/P2O5 = 1.25 in molar ratio) modified by small amounts of additives such as Na2O, MgO, TiO2 and ZrO2 were prepared after appropriate heat treatment for nucleation and crystallization. Based upon differential thermal analysis (DTA) results, a two-step heat treatment was used for crystal nucleation and growth. X-ray diffraction (XRD) analysis demonstrated that bioresorbable β-Ca2P2O7 (β-DCP), β-Na2CaP2O7, Na2Mg(PO3)4 phases were formed in the glass matrix depending upon the relative contents of the additives. By adding higher contents of Na2O and TiO2 and using CaO/P2O5 = 1.5-2.0, crystallization of β-DCP and Ca3(PO4)2 (β-TCP), and the formation of a dense structure in the glass ceramics were obtained. The precipitation of these crystals could be well distinguished at a magnification of 4000× and phases were dispersed in areas of micron size. A porous structure may be easily formed after the soluble phases are dissolved in physiological media. These glass ceramics with high CaO/P2O5 ratio, modified by the above mentioned additives are expected to find use as implants for bone replacement/regeneration and drug delivery carriers synergistically, because the soluble phases may act as drug delivery carriers and the porous structure will allow for bone ingrowth.
AB - Calcium phosphate glasses and glass ceramics (CaO/P2O5 = 1.25 in molar ratio) modified by small amounts of additives such as Na2O, MgO, TiO2 and ZrO2 were prepared after appropriate heat treatment for nucleation and crystallization. Based upon differential thermal analysis (DTA) results, a two-step heat treatment was used for crystal nucleation and growth. X-ray diffraction (XRD) analysis demonstrated that bioresorbable β-Ca2P2O7 (β-DCP), β-Na2CaP2O7, Na2Mg(PO3)4 phases were formed in the glass matrix depending upon the relative contents of the additives. By adding higher contents of Na2O and TiO2 and using CaO/P2O5 = 1.5-2.0, crystallization of β-DCP and Ca3(PO4)2 (β-TCP), and the formation of a dense structure in the glass ceramics were obtained. The precipitation of these crystals could be well distinguished at a magnification of 4000× and phases were dispersed in areas of micron size. A porous structure may be easily formed after the soluble phases are dissolved in physiological media. These glass ceramics with high CaO/P2O5 ratio, modified by the above mentioned additives are expected to find use as implants for bone replacement/regeneration and drug delivery carriers synergistically, because the soluble phases may act as drug delivery carriers and the porous structure will allow for bone ingrowth.
UR - http://www.scopus.com/inward/record.url?scp=0033706457&partnerID=8YFLogxK
UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-0033706457&origin=recordpage
U2 - 10.1016/S0022-3093(00)00115-0
DO - 10.1016/S0022-3093(00)00115-0
M3 - RGC 21 - Publication in refereed journal
SN - 0022-3093
VL - 272
SP - 14
EP - 21
JO - Journal of Non-Crystalline Solids
JF - Journal of Non-Crystalline Solids
IS - 1
ER -